Abstract
The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have